BOLT - Bolt Biotherapeutics, Inc.
4.3
-0.050 -1.163%
Share volume: 11,312
Last Updated: 03-06-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.14%
PREVIOUS CLOSE
CHG
CHG%
$4.35
-0.05
-0.01%
View ratios
| Fiscal Date | 12-31-2024 | 03-31-2025 | 09-30-2025 | |
|---|---|---|---|---|
| Fiscal Quarter | Q4 2024 | Q1 2025 | Q3 2025 | |
| Report Date | 03-24-2025 | 05-12-2025 | 11-12-2025 | |
| Assets | ||||
| Total Assets | 99.632 M | 85.862 M | 65.053 M | |
| Current Assets | 50.814 M | 42.509 M | 35.606 M | |
| Inventories | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 40.118 M | 30.447 M | 14.157 M | |
| Total Receivables | 0.000 | 0.000 | 0.000 | |
| Current Cash | 7.205 M | 8.391 M | 17.753 M | |
| Total Non-current Assets | 22.880 M | 19.115 M | 6.906 M | |
| Property Plant Equipment | 3.139 M | 2.065 M | 1.500 M | |
| Other Assets | 45.679 M | 41.288 M | 27.947 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||
| Total Liabilities and shareholders’ equity | 99.632 M | 85.862 M | 65.053 M | |
| Total liabilities | 42.434 M | 39.052 M | 32.952 M | |
| Total current liabilities | 15.856 M | 13.562 M | 9.966 M | |
| Accounts Payable | 1.507 M | 1.534 M | 1.518 M | |
| Other liabilities | 22.958 M | 22.441 M | 21.022 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 22.958 M | 22.441 M | 21.022 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 57.198 M | 46.810 M | 32.101 M | |
| Common stock | 484.504 M | 485.213 M | 486.259 M | |
| Retained earnings | -427.403 M | -438.443 M | -454.148 M |